Bottom Line Up Front
MSC therapy for degenerative disc disease and chronic low back pain is a growing application with Level 2–3 evidence. Intradiscal and epidural MSC injections have shown pain reduction in published comparative studies, but results vary significantly by severity. Treatment costs $5,000–$12,000 in Colombia. This is not a replacement for surgical intervention in cases of nerve compression or structural spinal instability.
Evidence Level: Level 2–3
Several comparative studies and large case series have been published showing meaningful pain reduction and functional improvement. Randomized controlled trials are underway. Evidence is growing but not yet definitive.
Chronic low back pain affects 80% of adults at some point in life, and degenerative disc disease is the most common underlying cause. The conventional pathway — physical therapy, NSAIDs, epidural steroid injections, and eventually spinal fusion or disc replacement — leaves many patients searching for alternatives that address the biological problem rather than masking symptoms or fusing the spine.
Who Is a Good Candidate
Patients with disc degeneration (loss of disc height, dehydration on MRI) without significant nerve compression are the best candidates. Patients with mild-to-moderate disc herniation may also benefit. Patients with severe nerve compression, spinal instability, or structural deformity should pursue surgical evaluation first. MSC therapy can complement post-surgical recovery but should not replace necessary surgery.
Important Caveat
If you have radiculopathy (shooting pain, numbness, or weakness in your legs), progressive neurological symptoms, or cauda equina syndrome, you need surgical evaluation, not stem cell therapy. These are conditions where delay can cause permanent nerve damage.
Is Stem Cell Therapy Appropriate for Your Back Pain?
Share your MRI and we'll provide an honest assessment of whether MSC therapy makes sense for your specific diagnosis.
Get Free Consultation